_tcm18-11397.gif )
Urgent high quality communications from across the chemical sciences.
Subscribers
Non-subscribers
- Purchase article PDF [£27 + taxes]
- Purchase article PDF member offer [£5 + taxes]
Free access
Feature Article
Chem. Commun., 2009, 3677 - 3692, DOI: 10.1039/b903035m
Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters
Jacob Andersen, Anders S. Kristensen, Benny Bang-Andersen and Kristian Strømgaard
The biogenic monoamine transporters are integral membrane proteins that perform active transport of extracellular dopamine, serotonin and norepinephrine into cells. These transporters are targets for therapeutic agents such as antidepressants, as well as addictive substances such as cocaine and amphetamine. Seminal advances in the understanding of the structure and function of this transporter family have recently been accomplished by structural studies of a bacterial transporter, as well as medicinal chemistry and pharmacological studies of mammalian transporters. This feature article focuses on antidepressant drugs that act on the serotonin and/or the norepinephrine transporters. Specifically, we focus on structure–activity relationships of these drugs with emphasis on relationships between their molecular properties and the current knowledge of transporter structure.
RSS feed